DI RENZO, Maria Flavia
DI RENZO, Maria Flavia
ONCOLOGIA
Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells
2018-01-01 Olivero, Martina; Erriquez, Jessica; Arigoni, Maddalena; Capellero, Sonia; D'Ambrosio, Concetta; Mittica, Gloria; Borella, Fulvio; Katsaros, Dionyssios; Privitera, Silvana; Berrino, Enrico; Venesio, Tiziana; Valabrega, Giorgio; Calogero, Raffaele; Renzo, Maria Flavia Di
Albright hereditary osteodystrphy and pseudohypoparathyroidism: three new mutation and common deletion in GNAS1.
2000-01-01 De Sanctis L; Romagnolo De Sanctis C; Lala R; Olivero M; Di Renzo MF; Dianzani I.
Cells lacking fumarase are protected from apoptosis through a HIF independent, AMPK dependent mechanism
2010-01-01 Di Renzo MF
Cisplatin unveils cancer cell addiction to the non-oncogene CDT2
2009-01-01 Olivero M; Dettori D; Lorenzato A; Martino C; Musiani D; Orlando G; Di Renzo MF
CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin
2010-01-01 Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF
DNA damage stress phenotype makes cancer cells addicted to a redundant CUL4 dependent pathway
2011-01-01 Olivero M; Dettori D; Pavan S; Di Renzo MF
Feline stk gene expression in cat mammary carcinomas
2002-01-01 De maria R.; MAGGIORA P.; PRAT M.; COMOGLIO PM.; CASTAGNARO M.; DI RENZO M.F.; BIOLATTI B
Genetics in renal cancer
2008-01-01 M. Olivero; A. Lorenzato; Di Renzo MF
HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel
2012-01-01 Pavan S ; Musiani D ; Torchiaro E ; Migliardi G ; Olivero M; Di Renzo MF
Inhibition of P90RSK Sensitizes Ovarian Cancer Cells to Apoptosis
2012-01-01 Torchiaro E ; Olivero M ; Pavan S ; Di Renzo MF
LE PROPRIETÀ ONCOSOPPRESSIVE INTRINSECHE DELL’ONCOGENE MET COME STRUMENTO DI MORTE APOPTOTICA DELLE CELLULE TUMORALI
2009-01-01 Di Renzo MF
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma
2009-01-01 Raffaella De Maria; Silvia Miretti; Selina Iussich; Martina Olivero;Emanuela Morello; Andrea Bertotti; James G. Christensen; Bartolomeo Biolatti; Roy A. Levine; Paolo Buracco; Maria Flavia Di Renzo
MET-oncogene transforms human bone-derived cells by targeting committed progenitors.
2010-01-01 Dani N; Olivero M; Lorenzato A; Cuvertino S; Patane’ S; Van Duist M; Mareschi K; Fagioli F; Di Renzo MF
MET-ONCOGENE TRANSFORMS HUMAN PRIMARY BONE-DERIVED CELLS BY TARGETING OSTEOPROGENITORS
2010-01-01 N Dani; M Olivero; S Patane; M VanDuist; K Mareschi(1); F Fagioli(1); Di Renzo MF
Molecular and immunohistochemical studies on RON and MET oncogenes in cat mammary tumors
2000-01-01 CASTAGNARO M; DE MARIA R; BIOLATTI B; PRATT M; MAGGIORA P; DI RENZO F
Overexpression of c.Met oncogene in canine osteosarcomas and cells lines
2006-01-01 RAFFAELLA DE MARIA; SILVIA MIRETTI; SELINA IUSSICH; MARTINA OLIVERO; MARIA FLAVIA DI RENZO; PAOLO BURACCO; BARTOLOMEO BIOLATTI
P38MAPK highlights the dark side of Met/HGF pathway in ovarian cancer
2007-01-01 Lorenzato A; Coltella N; Olivero M; Martino C; Dettori D; Cossu C; Calogero R; Di Renzo MF
RON and MET oncogene expression in cat mammary tumors
2001-01-01 Castagnaro M.; De maria R.; Maggiora P.; Prat M.; Di renzo MF.; Biolatti B
RON and MET oncogene expression in cat mammary tumors
2000-01-01 DE MARIA R.; CASTAGNARO M.; B. BIOLATTI; PRATT M.; MAGGIORA P.; DI RENZO F.
Screening genetico dei tumori del rene
2009-01-01 Di Renzo MF
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Abstract 3102: Identification of actionable cancer genes and treatment options for metastatic ovarian carcinomas using patient-derived xenografts and PDX-derived tumor cells | 2018 | Olivero, Martina; Erriquez, Jessica; Arigoni, Maddalena; Capellero, Sonia; D'Ambrosio, Concetta; Mittica, Gloria; Borella, Fulvio; Katsaros, Dionyssios; Privitera, Silvana; Berrino, Enrico; Venesio, Tiziana; Valabrega, Giorgio; Calogero, Raffaele; Renzo, Maria Flavia Di | |
Albright hereditary osteodystrphy and pseudohypoparathyroidism: three new mutation and common deletion in GNAS1. | 2000 | De Sanctis L; Romagnolo De Sanctis C; Lala R; Olivero M; Di Renzo MF; Dianzani I. | |
Cells lacking fumarase are protected from apoptosis through a HIF independent, AMPK dependent mechanism | 2010 | Di Renzo MF | |
Cisplatin unveils cancer cell addiction to the non-oncogene CDT2 | 2009 | Olivero M; Dettori D; Lorenzato A; Martino C; Musiani D; Orlando G; Di Renzo MF | |
CSE1L as a Potential Target to Sensitize Ovarian Cancer Cells to Cisplatin | 2010 | Lorenzato A; Olivero M; Calogero R., Martino C, Musiani D, Dani N, Di Renzo MF | |
DNA damage stress phenotype makes cancer cells addicted to a redundant CUL4 dependent pathway | 2011 | Olivero M; Dettori D; Pavan S; Di Renzo MF | |
Feline stk gene expression in cat mammary carcinomas | 2002 | De maria R.; MAGGIORA P.; PRAT M.; COMOGLIO PM.; CASTAGNARO M.; DI RENZO M.F.; BIOLATTI B | |
Genetics in renal cancer | 2008 | M. Olivero; A. Lorenzato; Di Renzo MF | |
HSP27 is Involved in Ovarian Cancer Cell Motility and Response to Paclitaxel | 2012 | Pavan S ; Musiani D ; Torchiaro E ; Migliardi G ; Olivero M; Di Renzo MF | |
Inhibition of P90RSK Sensitizes Ovarian Cancer Cells to Apoptosis | 2012 | Torchiaro E ; Olivero M ; Pavan S ; Di Renzo MF | |
LE PROPRIETÀ ONCOSOPPRESSIVE INTRINSECHE DELL’ONCOGENE MET COME STRUMENTO DI MORTE APOPTOTICA DELLE CELLULE TUMORALI | 2009 | Di Renzo MF | |
met oncogene activation qualifies spontaneous canine osteosarcoma as a suitable pre-clinical model of human osteosarcoma | 2009 | Raffaella De Maria; Silvia Miretti; Selina Iussich; Martina Olivero;Emanuela Morello; Andrea Bertotti; James G. Christensen; Bartolomeo Biolatti; Roy A. Levine; Paolo Buracco; Maria Flavia Di Renzo | |
MET-oncogene transforms human bone-derived cells by targeting committed progenitors. | 2010 | Dani N; Olivero M; Lorenzato A; Cuvertino S; Patane’ S; Van Duist M; Mareschi K; Fagioli F; Di Renzo MF | |
MET-ONCOGENE TRANSFORMS HUMAN PRIMARY BONE-DERIVED CELLS BY TARGETING OSTEOPROGENITORS | 2010 | N Dani; M Olivero; S Patane; M VanDuist; K Mareschi(1); F Fagioli(1); Di Renzo MF | |
Molecular and immunohistochemical studies on RON and MET oncogenes in cat mammary tumors | 2000 | CASTAGNARO M; DE MARIA R; BIOLATTI B; PRATT M; MAGGIORA P; DI RENZO F | |
Overexpression of c.Met oncogene in canine osteosarcomas and cells lines | 2006 | RAFFAELLA DE MARIA; SILVIA MIRETTI; SELINA IUSSICH; MARTINA OLIVERO; MARIA FLAVIA DI RENZO; PAOLO BURACCO; BARTOLOMEO BIOLATTI | |
P38MAPK highlights the dark side of Met/HGF pathway in ovarian cancer | 2007 | Lorenzato A; Coltella N; Olivero M; Martino C; Dettori D; Cossu C; Calogero R; Di Renzo MF | |
RON and MET oncogene expression in cat mammary tumors | 2001 | Castagnaro M.; De maria R.; Maggiora P.; Prat M.; Di renzo MF.; Biolatti B | |
RON and MET oncogene expression in cat mammary tumors | 2000 | DE MARIA R.; CASTAGNARO M.; B. BIOLATTI; PRATT M.; MAGGIORA P.; DI RENZO F. | |
Screening genetico dei tumori del rene | 2009 | Di Renzo MF |